DrugPatentWatch Database Preview

Msd Merck Co Company Profile

« Back to Dashboard

What is the competitive landscape for MSD MERCK CO, and what generic alternatives to MSD MERCK CO drugs are available?

MSD MERCK CO has four approved drugs.

There are two US patents protecting MSD MERCK CO drugs.

There are eighty-six patent family members on MSD MERCK CO drugs in forty-four countries and seventeen supplementary protection certificates in seven countries.

Summary for Msd Merck Co

International Patents:	86
US Patents:	2
Tradenames:	3
Ingredients:	3
NDAs:	4

Drugs and US Patents for Msd Merck Co

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Msd Merck Co	SINGULAIR	montelukast sodium	TABLET, CHEWABLE;ORAL	020830-001	Feb 20, 1998	AB	RX	Yes	Yes
Msd Merck Co	SINGULAIR	montelukast sodium	TABLET;ORAL	020829-002	Feb 20, 1998	AB	RX	Yes	Yes
Msd Merck Co	EMEND	aprepitant	FOR SUSPENSION;ORAL	207865-001	Dec 17, 2015		RX	Yes	Yes	6,096,742		Y	Y
Msd Merck Co	ZOCOR	simvastatin	TABLET;ORAL	019766-001	Dec 23, 1991	AB	RX	Yes	No
Msd Merck Co	ZOCOR	simvastatin	TABLET;ORAL	019766-005	Jul 10, 1998	AB	RX	Yes	Yes

Expired US Patents for Msd Merck Co

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Msd Merck Co	ZOCOR	simvastatin	TABLET;ORAL	019766-002	Dec 23, 1991	RE36481*PED
Msd Merck Co	ZOCOR	simvastatin	TABLET;ORAL	019766-003	Dec 23, 1991	RE36520*PED
Msd Merck Co	ZOCOR	simvastatin	TABLET;ORAL	019766-001	Dec 23, 1991	RE36481*PED
Msd Merck Co	ZOCOR	simvastatin	TABLET;ORAL	019766-001	Dec 23, 1991	RE36520*PED
Msd Merck Co	EMEND	aprepitant	FOR SUSPENSION;ORAL	207865-001	Dec 17, 2015	6,096,742

Paragraph IV (Patent) Challenges for MSD MERCK CO drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Capsule	40 mg, 80 mg and 125 mg		2008-11-03
	Injection	150 mg/vial		2012-01-25
	Tablets	10 mg		2007-02-20
	Injection	115 mg/vial		2012-01-25
	for Oral Suspension	125 mg/Kit		2016-11-23
	Chewable Tablets	4 mg and 5 mg		2006-12-26

Non-Orange Book US Patents for Msd Merck Co

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
6,229,010	Polymorphic form of a tachykinin receptor antagonist
6,583,142	Polymorphic form of a tachykinin receptor antagonist
6,432,953	Polymorphic form of a tachykinin receptor antagonist

International Patents for Msd Merck Co Drugs

Country	Document Number	Estimated Expiration
Malaysia	155911
Argentina	013160
Norway	996549
Czech Republic	295410
Indonesia	23191

Supplementary Protection Certificates for Msd Merck Co Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C/GB98/025	United Kingdom		PRODUCT NAME: MONTELUKAST, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREFERABLY MONTELUKAST SODIUM; REGISTERED: FI 12766 19970825; FI 12767 19970825; UK 00025/0357 19980115; UK 00025/0358 19980115
C0019	France		PRODUCT NAME: FOSAPREPITANT DIMEGLUMINE; REGISTRATION NO/DATE: EU/1/07/437/001 20080111
C/GB08/021	United Kingdom		PRODUCT NAME: FOSAPREPITANT AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR THE BIS(N-METHYL-D-GLUCAMINE)SALT; REGISTERED: UK EU/1/07/437/001 20080111; UK EU/1/07/437/002 20080111
2004000026	Germany		PRODUCT NAME: EZETIMIB ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON IN KOMBINATION MIT SIMVASTATIN; NAT. REGISTRATION NO/DATE: 58866.00.00 58866.01.00 58866.02.00 58866.03.00 58870.00.00 58870.01.00 58870.02.00 58870.03.00 58874.00.00 58874.01.00 58874.02.00 58874.03.00 58878.00.00 58878.01.00 58878.02.00 58878.03.00 20040402 FIRST REGISTRATION: DE 58866.00.00 - 58866.03.00 58870.00.00 - 58870.03.00 58874.00.00 - 58874.03.00 58878.00.00 - 58878.03.00 20040402
2004002	Lithuania		PRODCUT NAME: 5-[[(2R,3S)-2-[(1R)-1-[3,5-BIS(TRIFLUORMETIL)FENIL]ETOKSI]-3-(4-FLUORFENIL)-4-MORFOLINIL]METIL]-1,2-DIHIDRO-3H-1,2,4-TRIAZOL-3-ONAS (APREPITANTAS); REGISTRATION NO./DATE: EU/1/03/262/001-006/20031111

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Msd Intl
• Msd Intl Gmbh
• Msd Merck Co